Sigma-Aldrich
Sigma-Aldrich officials detail recent developments
Published in Medical Patent Law Weekly, November 22nd, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Sigma-Aldrich.
Report 1: Sigma-Aldrich Research Biotech, a division of Sigma-Aldrich (SIAL), has launched the PhosphoProfile I phosphopeptide enrichment kit, a new kit for the enrichment of phosphopeptides.
The technology is based on a novel Ga+3 chelate on silica that provides a robust method for phosphoproteomics. This new approach offers several advantages to proteomics researchers, including very low nonspecific binding, no bias in selectivity of phosphorylation state, high...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
More Articles from Medical Patent Law Weekly
- Business & Finance
Cytokinetics reports third quarter 2006 financial results and clinical highlights - Business & Finance
Enpath Medical reports 22% increase in third quarter revenues - Business Update
Agilent offers licenses for technology to place test targets on PCB signal traces - Business Update
QLT announces third quarter results for 2006, updates guidance and implements cost reductions - Business Update
UTEK Corporation and GammaCan International sign strategic alliance agreement - Collaborations
Orexo announces collaboration with Doxa - More from this issue of Medical Patent Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
